From: Recent advances in extracellular vesicle engineering and its applications to regenerative medicine
No. | Engineered materials | Method | Targeting cell | Ref. |
---|---|---|---|---|
1 | PDGFR-RVG, hnRNPA2B1expressed/mirSilencer | lentivirus | HEK293T | [51] |
2 | RVG/BDNF | lentivirus | HEK293T | [52] |
3 | SERPINA5 protein | lentivirus | HEK293 | [57] |
4 | Serpin protein | lentivirus | HEK293 | [58] |
5 | miR-146a | lentivirus | PMSC | [56] |
6 | miR-214-3p | lentivirus | UCMSC | [55] |
7 | miR-133-3p | lentivirus | UCMSC | [54] |
8 | Tat protein | Lipofectamine | HEK293T | [59] |
9 | Ldlr mRNA | Lipofectamine | HEK293T | [60] |
10 | Protein drug (srIkB) | Effectene Transfection Reagent | HEK293T | [61] |
11 | Protein drug (srIkB) | Effectene Transfection Reagent | HEK293T | [62] |
12 | Protein drug (srIkB) | Effectene Transfection Reagent | HEK293T | [63] |